AirTyme GTX75, User Manual, Page: 140 / 159

139 139
SAFETY
The interpretation of epidemiological studies is hampered by difficulties in
measuring actual RF exposure during day-to-day use of wireless phones.
Many factors affect this measurement, such as the angle at which the
phone is held, or which model of phone is used.
6. What is FDA doing to find out more about the possible
health effects of wireless phone RF?
FDA is working with the U.S. National Toxicology Program and with groups
of investigators around the world to ensure that high priority animal
studies are conducted to address important questions about the effects of
exposure to radiofrequency energy (RF).
FDA has been a leading participant in the World Health Organization
International Electromagnetic Fields (EMF) Project since its inception in
1996. An influential result of this work has been the development of a
detailed agenda of research needs that has driven the establishment of
new research programs around the world. The Project has also helped
develop a series of public information documents on EMF issues.
FDA and the Cellular Telecommunications & Internet Association (CTIA)
have a formal Cooperative Research and Development Agreement
(CRADA) to doresearch on wireless phone safety. FDA provides the
scientific oversight, obtaining input from experts in government, industry,
and academic organizations. CTIA-funded research is conducted through
contracts to independent investigators. The initial research will include
both laboratory studies and studies of wireless phone users. The CRADA
will also include a broad assessment of additional research needs in the
context of the latest research developments around the world.